 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | CD19-CD34t metabolically programmed CAR transduced T-cells / Medical University of South Carolina
Enrollment open, Phase classification, CAR T-Cell Therapy: Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL (clinicaltrials.gov) - Dec 5, 2023
P1/2, N=27, Recruiting, Sponsor: Medical University of South Carolina
Not yet recruiting --> Recruiting | Phase classification: P1b --> P1/2
- | CD19-CD34t metabolically programmed CAR transduced T-cells / Medical University of South Carolina
Trial completion date, Trial initiation date, Trial primary completion date, CAR T-Cell Therapy: Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL (clinicaltrials.gov) - Jun 23, 2023
P1b, N=27, Not yet recruiting, Sponsor: Medical University of South Carolina
Not yet recruiting --> Recruiting | Phase classification: P1b --> P1/2 Trial completion date: Feb 2026 --> Dec 2026 | Initiation date: Apr 2023 --> Aug 2023 | Trial primary completion date: Feb 2025 --> Aug 2025
- | CD19-CD34t metabolically programmed CAR transduced T-cells / Medical University of South Carolina
New P1 trial, CAR T-Cell Therapy: Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL (clinicaltrials.gov) - Jan 27, 2023
P1b, N=27, Not yet recruiting, Sponsor: Medical University of South Carolina